Arabic Arabic English English French French German German
dark

Arch Scientists Awarded CIHR Grant to Study LSALT for the Prevention of Chronic Disease

Arch Biopartners Inc. announced that Arch scientists have been awarded a Canadian Institutes of Health Research Team Grant worth $750,000 to study the potential benefit for the LSALT peptide to prevent inflammation in chronic kidney and lung diseases. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Health Volunteer Center Participates in Serving Pilgrims during this Year’s Hajj Season

Next Post

Kintor Pharmaceutical Receives IND Clearance by the U.S. FDA for GT20029 to Treat Androgenetic Alopecia and Acne

Related Posts
Total
0
Share